Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BRAFV600E mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies.
Trivieri N, Pracella R, Cariglia MG, Panebianco C, Parrella P, Visioli A, Giani F, Soriano AA, Barile C, Canistro G, Latiano TP, Dimitri L, Bazzocchi F, Cassano D, Vescovi AL, Pazienza V, Binda E. Trivieri N, et al. Among authors: parrella p. J Exp Clin Cancer Res. 2020 Dec 14;39(1):285. doi: 10.1186/s13046-020-01801-w. J Exp Clin Cancer Res. 2020. PMID: 33317591 Free PMC article.
High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome.
Barbano R, Copetti M, Perrone G, Pazienza V, Muscarella LA, Balsamo T, Storlazzi CT, Ripoli M, Rinaldi M, Valori VM, Latiano TP, Maiello E, Stanziale P, Carella M, Mangia A, Pellegrini F, Bisceglia M, Muda AO, Altomare V, Murgo R, Fazio VM, Parrella P. Barbano R, et al. Among authors: parrella p. Int J Cancer. 2011 Aug 1;129(3):536-45. doi: 10.1002/ijc.25736. Epub 2010 Dec 9. Int J Cancer. 2011. PMID: 21064098
A miRNA signature for defining aggressive phenotype and prognosis in gliomas.
Barbano R, Palumbo O, Pasculli B, Galasso M, Volinia S, D'Angelo V, Icolaro N, Coco M, Dimitri L, Graziano P, Copetti M, Valori VM, Maiello E, Carella M, Fazio VM, Parrella P. Barbano R, et al. Among authors: parrella p. PLoS One. 2014 Oct 3;9(10):e108950. doi: 10.1371/journal.pone.0108950. eCollection 2014. PLoS One. 2014. PMID: 25279461 Free PMC article.
TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival.
Micale L, Fusco C, Fontana A, Barbano R, Augello B, De Nittis P, Copetti M, Pellico MT, Mandriani B, Cocciadiferro D, Parrella P, Fazio VM, Dimitri LM, D'Angelo V, Novielli C, Larizza L, Daga A, Merla G. Micale L, et al. Among authors: parrella p. BMC Cancer. 2015 Jun 16;15:470. doi: 10.1186/s12885-015-1449-9. BMC Cancer. 2015. PMID: 26077989 Free PMC article.
BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.
Roma C, Rachiglio AM, Pasquale R, Fenizia F, Iannaccone A, Tatangelo F, Antinolfi G, Parrella P, Graziano P, Sabatino L, Colantuoni V, Botti G, Maiello E, Normanno N. Roma C, et al. Among authors: parrella p. Cancer Biol Ther. 2016 Aug 2;17(8):840-8. doi: 10.1080/15384047.2016.1195048. Cancer Biol Ther. 2016. PMID: 27261210 Free PMC article.
Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study.
Colucci G, Giuliani F, Garufi C, Mattioli R, Manzione L, Russo A, Lopez M, Parrella P, Tommasi S, Copetti M, Daniele B, Pisconti S, Tuveri G, Silvestris N, Maiello E. Colucci G, et al. Among authors: parrella p. Oncology. 2010;79(5-6):415-22. doi: 10.1159/000323279. Epub 2011 Apr 7. Oncology. 2010. PMID: 21474966 Clinical Trial.
105 results